Advancing and Personalizing Kidney Disease Care

0
Advancing and Personalizing Kidney Disease Care

Dr. Manuela Stauss-Grabo joined Fresenius Medical Care in 2013 and has since made significant contributions to the field of clinical research in nephrology. With over 20 years of experience, she currently serves as the Senior Vice President of Global Clinical Research in the Global Medical Office (GMO), where she leads a dedicated team focused on advancing the understanding and treatment of kidney disease. Dr. Stauss-Grabo’s extensive background in biology and clinical research equips her with a unique perspective on the complexities of kidney health. Her leadership is instrumental in designing and implementing clinical studies that generate robust evidence, ultimately aimed at improving patient outcomes. She is passionate about bridging the gap between scientific research and practical application, ensuring that findings translate into effective therapies for patients suffering from kidneyrelated conditions. Under her guidance, the Fresenius Medical Care Clinical Research team, a global team of researchers, manages a diverse portfolio of national and international clinical studies. The team is responsible for overseeing all phases of research—from strategic concept development to detailed planning and execution—ensuring that each study adheres to the highest standards of quality, safety and compliance.

Dr. Stauss-Grabo received her Diploma in Biology from the Julius-Maximilians-University in Wuerzburg, Germany as a major in Biochemistry and completed her doctoral thesis titled “Investigations on the Pharmacokinetics of the Ivy Saponin Alpha-Hederin” under the supervision of Prof Dr. Manfred Haake at the Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg, Germany. This pioneering research provided the first comprehensive description of how alpha-hederin, a key saponin found in Hedera helix (common ivy), is processed in the body. The study’s findings were significant, as they laid the groundwork for understanding the medicinal properties of ivy extracts, which have long been used in traditional medicine for respiratory conditions in many countries worldwide.

Dr. Stauss-Grabo is committed to fostering collaboration among stakeholders in the healthcare community, including researchers, clinicians, and regulatory bodies. Her efforts not only enhance the scientific rigor of clinical trials but also promote innovative approaches to tackling kidney disease on a global scale. Through her work at Fresenius Medical Care, Dr. Stauss-Grabo continues to make a profound impact on the lives of patients by driving forward initiatives that aim to enhance treatment options and improve overall health outcomes in nephrology.

link

Leave a Reply

Your email address will not be published. Required fields are marked *